Ninjacof

Manufacturer: Centurion Labs, LLC
Effective date: 2025-12-29
Label type: HUMAN OTC DRUG LABEL
Version: 24
Source: full-release
Hydrated at: 2026-06-01 01:29:00

Label at a glance#

ProductNinjacof

Active ingredientCHLOPHEDIANOL HYDROCHLORIDE, PYRILAMINE MALEATE

Label structure12 sections

Dosage and administration

Directions Do not exceed recommended dosage. Use calibrated measuring device for administering the drug to a child. Adults and children 12 years of age and over: 2 teaspoonfuls (10 ml) every 6 to 8 hours, not to exceed 6 teaspoonfuls in 24 hours, or as directed by a doctor. Children 6 to under 12 years of age: 1 teaspoonful (5 ml) every 6 to 8 hours, not to exceed 3 teaspoonfuls in 24 hours, or as directed by a d...

Contacts and useful links#

PhoneLabel contact1-866-959-4880

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredients (in each 5 ml) Purpose
Chlophedianol HCI 12.5 mg ..................................... Antitussive
Pyrilamine Maleate 12.5 mg ................................. Antihistamine

Purpose

OTC - PURPOSE SECTION

Antitussive

Antihistamine

INDICATIONS & USAGE SECTION

Uses Temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:

cough due to minor throat and bronchial irritation
calms the cough control center and relieves coughing
runny nose
sneezing
itching of the nose and throat
itchy, watery eyes

WARNINGS SECTION

WARNINGS
Do not exceed recommended dosage

DO NOT USE IF PRINTED SAFETY SEAL IS MISSING OR BROKEN

If you are now taking prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions or Parkinsons disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have

A cough that lasts or is chronic such as occurs with smoking, asthma, or emphysema
A cough that occurs with too much phlegm (mucus)

Ask a doctor or pharmacist before us if you are:

Taking sedatives or tranquilizers
If you have a breathing problem such as emphysema or chronic bronchitis
If you have glaucoma
If you have difficult in urination due to enlargement of the prostate gland

OTC - WHEN USING SECTION

When using this product

Excitability may occur, especially in children
Marked drowsiness may occur
Avoid alcoholic drinks
Alcohol, sedatives, and tranquilizers may increase the drowsiness effect
Be careful when driving a motor vehicle or operating machinery

OTC - DO NOT USE SECTION

Stop use and ask a doctor if

Nervousness, dizziness, or sleeplessness occurs
Symptoms do not improve within 7 days or are accompanied by a fever, rash, or persistent headache. A persistent cough may be a sign of a serious condition.
New symptoms occur

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding

Ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center immediately.

Dosage and Administration

DOSAGE & ADMINISTRATION SECTION

Directions

Do not exceed recommended dosage. Use calibrated measuring device for administering the drug to a child.


Adults and children 12 years of age and over:	2 teaspoonfuls (10 ml) every 6 to 8 hours, not to exceed 6 teaspoonfuls in 24 hours, or as directed by a doctor.
Children 6 to under 12 years of age:	1 teaspoonful (5 ml) every 6 to 8 hours, not to exceed 3 teaspoonfuls in 24 hours, or as directed by a doctor.
Children under 6 years of age:	Consult a doctor.

Other Information Store at 20° -25°C (68°-77°F); excursions permitted to 15°-30°C (59° - 86°F). [See USP Controlled Room Temperature].

INACTIVE INGREDIENT SECTION

Inactive Ingredients Citric Acid, Glycerin, Natural & Artificial Flavors, Propylene Glycol, Purified Water, Sodium Benzoate, Sodium Citrate, Sucralose

OTC - QUESTIONS SECTION

Questions? Comments?
To report a serious adverse event or obtain product information, contact 1-866-959-4880

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image description

23359-032-16

Ninjacof

Antitussive, Antihistamine

Each teaspoonful (5mL) Contains:

Chlophendianol HCl......................12.5mg

Pyrilamine Maleate.......................12.5mg

Alcohol Free Dye Free, Sugar Free

Cotton Candy Flavor

Centurion

16 fl oz (473 mL)

Manufactured for Centurion Labs, LLC Birmingham, AL 35243

Rev: 2/2015

EXP:

Lot:

image description

23359-032-10

Ninjacof

Antitussive, Antihistamine

Each teaspoonful (5mL) Contains:

Chlophendianol HCl......................12.5mg

Pyrilamine Maleate.......................12.5mg

Alcohol Free Dye Free, Sugar Free

Cotton Candy Flavor

Centurion

16 fl oz (473 mL)

Manufactured for Centurion Labs, LLC Birmingham, AL 35243

Rev: 2/2015

EXP:

Lot:

image description

23359-032-04

Ninjacof

Antitussive, Antihistamine

Each teaspoonful (5 mL) Contains:

Chlophendianol HCl......................12.5mg

Pyrilamine Maleate.......................12.5mg

Alcohol Free Dye Free, Sugar Free

Cotton Candy Flavor

Centurion

16 fl oz (473 mL)

Manufactured for Centurion Labs, LLC Birmingham, AL 35243

Rev: 2/2015

EXP:

Lot:

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1593749	chlophedianol HCl 12.5 MG / pyrilamine maleate 12.5 MG in 5 mL Oral Solution	PSN	24
1593756	Ninjacof 12.5 MG / 12.5 MG in 5 mL Oral Solution	PSN	24
1593756	chlophedianol hydrochloride 2.5 MG/ML / pyrilamine maleate 2.5 MG/ML Oral Solution [Ninjacof]	SBD	24
1593749	chlophedianol hydrochloride 2.5 MG/ML / pyrilamine maleate 2.5 MG/ML Oral Solution	SCD	24
1593749	chlophedianol hydrochloride 12.5 MG / pyrilamine maleate 12.5 MG per 5 ML Oral Solution	SY	24
1593756	Ninjacof (chlophedianol hydrochloride 12.5 MG / pyrilamine maleate 12.5 MG) per 5 ML Oral Solution	SY	24

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
23359-032-04	Ninjacof	120 mL in 1 BOTTLE	SOLUTION	120	24
23359-032-10	Ninjacof	10 mL in 1 BOTTLE	SOLUTION	10	24
23359-032-16	Ninjacof	473 mL in 1 BOTTLE	SOLUTION	473	24

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
23359-032-16	ML - Milliliter	23359-032	adf69f2b-d87c-4fb4-a599-c82733d748ac	1	2014-11-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
CHLOPHEDIANOL HYDROCHLORIDE	ACTIVE INGREDIENT	69QQ58998Y	3
Pyrilamine Maleate	ACTIVE INGREDIENT	R35D29L3ZA	3
CHLOPHEDIANOL	ACTIVE MOIETY	42C50P12AP	3
Pyrilamine	ACTIVE MOIETY	HPE317O9TL	3
Methylparaben	INACTIVE INGREDIENT	A2I8C7HI9T	3
Polyethylene Glycol 400	INACTIVE INGREDIENT	B697894SGQ	3
Propylene Glycol	INACTIVE INGREDIENT	6DC9Q167V3	3
Propylparaben	INACTIVE INGREDIENT	Z8IX2SC1OH	3
Sodium Citrate	INACTIVE INGREDIENT	1Q73Q2JULR	3
Sucralose	INACTIVE INGREDIENT	96K6UQ3ZD4	3
Water	INACTIVE INGREDIENT	059QF0KO0R	3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

Ninjacof
chlophedianol hcl and pyrilamine maleate
ANHYDROUS CITRIC ACID
PROPYLENE GLYCOL
SODIUM BENZOATE
WATER
SODIUM CITRATE
SUCRALOSE
CHLOPHEDIANOL HYDROCHLORIDE
CHLOPHEDIANOL
PYRILAMINE MALEATE
PYRILAMINE
GLYCERIN

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
23359-032	23359-032-16, 23359-032-10, 23359-032-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ANHYDROUS CITRIC ACID	XF417D3PSL	IACT
PROPYLENE GLYCOL	6DC9Q167V3	IACT
SODIUM BENZOATE	OJ245FE5EU	IACT
WATER	059QF0KO0R	IACT
SODIUM CITRATE	1Q73Q2JULR	IACT
SUCRALOSE	96K6UQ3ZD4	IACT
CHLOPHEDIANOL HYDROCHLORIDE	69QQ58998Y	ACTIB
PYRILAMINE MALEATE	R35D29L3ZA	ACTIB
GLYCERIN	PDC6A3C0OX	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 20 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Propylene Glycol	PROPYLENE GLYCOL	6DC9Q167V3	SOLUTION / ORAL		22602 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	SOLUTION / ORAL		346 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
Sucralose	SUCRALOSE	96K6UQ3ZD4	SOLUTION / ORAL		800 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
Propylene Glycol	PROPYLENE GLYCOL	6DC9Q167V3	SOLUTION / ORAL		22602 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
Polyethylene Glycol 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SOLUTION / ORAL		70200 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
Propylene Glycol	PROPYLENE GLYCOL	6DC9Q167V3	SOLUTION / ORAL		22602 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
Propylparaben	PROPYLPARABEN	Z8IX2SC1OH	SOLUTION / ORAL	100 mg		Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	SOLUTION / ORAL		346 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
Propylparaben	PROPYLPARABEN	Z8IX2SC1OH	SOLUTION / ORAL	100 mg		Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
Sucralose	SUCRALOSE	96K6UQ3ZD4	SOLUTION / ORAL		800 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
Sucralose	SUCRALOSE	96K6UQ3ZD4	SOLUTION / ORAL		800 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
Polyethylene Glycol 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SOLUTION / ORAL		70200 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	SOLUTION / ORAL		346 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
Propylparaben	PROPYLPARABEN	Z8IX2SC1OH	SOLUTION / ORAL	100 mg		Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
Polyethylene Glycol 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SOLUTION / ORAL		70200 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
Propylparaben	PROPYLPARABEN	Z8IX2SC1OH	SOLUTION / ORAL	100 mg		Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
Propylene Glycol	PROPYLENE GLYCOL	6DC9Q167V3	SOLUTION / ORAL		22602 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	SOLUTION / ORAL		346 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
Polyethylene Glycol 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SOLUTION / ORAL		70200 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
Sucralose	SUCRALOSE	96K6UQ3ZD4	SOLUTION / ORAL		800 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ninjacof	CHLOPHEDIANOL HCL AND PYRILAMINE MALEATE	Centurion Labs, LLC	e2bca40f-9c27-ec8b-2ff0-ef9847ba2037	2025-12-29	Warnings	Exact identifier ndc (package): 23359-032-16 ndc (package): 23359-032-10 ndc (package): 23359-032-04 ndc (product): 23359-032 ndc11 (package): 23359003216 ndc11 (package): 23359003210 ndc11 (package): 23359003204 spl id: 47183553-1992-6cd0-e063-6394a90a48dc spl set id: e2bca40f-9c27-ec8b-2ff0-ef9847ba2037

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.